FDA808m-2 : Multiple organ tumor (24 organs ) and normal (6 organs) tissue array, with grade and TNM/Stage (AJCC 8th edition), 71 cases/72 cores (core size 1.5mm), replacing FDA808l-2
FDA808m-2 |
Microarray Panel | Multiple organ tumor and normal tissue microarray, 24 tumor organs /54 cases, 6 normal organs /17 cases, single core per case | |
Cores | 72 | |
Cases | 71 | |
Row number | 8 | |
Column number | 9 | |
Core Diameter (mm) | 1.5 | |
Thickness (µm) | 5 | |
Quality Control | H&E and IHC confirmed | |
Tissue Array Type | FFPE | |
Species | Human | |
Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | |
Notes | 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours. In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Legend: | Bla - Bladder,
Bon - Bone/Femur,
Bre - Breast,
Bro - Broad ligament/Left,
Cer - Cervix,
Col - Colon,
Eso - Esophagus,
Kid - Kidney,
Liv - Liver,
Lun - Lung,
Lym - Lymph node/Celiac,
Ova - Ovary,
Pan - Pancreas,
Pel - Pelvic cavity,
Per - Pericardium,
Pro - Prostate,
Rec - Rectum,
Ret - Retroperitoneum,
Rig - Right thigh,
Ske - Skeletal muscle,
Ski - Skin/Left neck,
Sma - Small intestine,
Spl - Spleen,
Sto - Stomach,
Tes - Testis,
Thy - Thyroid gland,
Ute - Uterus,
per - pericardium
|
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Pos. | No. | Age | Sex | Organ/Anatomic Site | Pathology diagnosis | TNM | Grade | Stage | Type | Image |
---|
A1 | 1 | 56 | F | Uterus | NAT endometrium tissue | - | - | - | NAT | |
A2 | 2 | 42 | F | Uterus | NAT endometrium tissue | - | - | - | NAT | |
A3 | 3 | 58 | F | Uterus | NAT endometrium tissue | - | - | - | NAT | |
A4 | 4 | 50 | F | Cervix | Cancer adjacent cervix tissue | - | - | - | AT | |
A5 | 5 | 49 | F | Cervix | Cancer adjacent cervix tissue | - | - | - | AT | |
A6 | 6 | 51 | F | Cervix | Cancer adjacent cervix tissue | - | - | - | AT | |
A7 | 7 | 23 | M | Skeletal muscle | Skeletal muscle tissue | - | - | - | Normal | |
A8 | 8 | 34 | M | Skeletal muscle | Skeletal muscle tissue | - | - | - | Normal | |
A9 | 9 | 27 | M | Skeletal muscle | Skeletal muscle tissue | - | - | - | Normal | |
B1 | 10 | 50 | M | Skin | Skin tissue | - | - | - | Normal | |
B2 | 11 | 47 | M | Skin | Skin tissue | - | - | - | Normal | |
B3 | 12 | 43 | F | Skin | Skin tissue | - | - | - | Normal | |
B4 | 13 | 19 | F | Peripheral nerve | Peripheral nerve tissue | - | - | - | Normal | |
B5 | 14 | 21 | F | Peripheral nerve | Peripheral nerve tissue | - | - | - | Normal | |
B6 | 15 | 50 | M | Peripheral nerve | Peripheral nerve tissue | - | - | - | Normal | |
B7 | 16 | 23 | M | Pericardium | mesothelium tissue | - | - | - | Normal | |
B8 | 17 | 47 | M | Lung | mesothelium tissue | - | - | - | Normal | |
B9 | 18 | 45 | F | Lung | mesothelium tissue | - | - | - | Normal | |
C1 | 19 | 10 | F | Cerebrum | Glioblastoma | - | 4 | - | Malignant | |
C2 | 20 | 59 | F | Cerebrum | Glioblastoma | - | 4 | - | Malignant | |
C3 | 21 | 41 | M | Cerebrum | Glioblastoma | - | 4 | - | Malignant | |
C4 | 22 | 48 | F | Cerebrum | Glioblastoma | - | 4 | - | Malignant | |
C5 | 23 | 55 | F | Ovary | Endometrioid adenocarcinoma | T3cN1M0 | 2 | IIIC | Malignant | |
C6 | 24 | 50 | F | Ovary | Mucinous adenocarcinoma | T3cNxM1b | 2 | IVB | Malignant | |
C7 | 25 | 23 | F | Pancreas | Islet cell tumor | - | - | - | Potentially malignant | |
C8 | 26 | 57 | F | Pancreas | Duct adenocarcinoma | T3N0M0 | 2 | IIA | Malignant | |
C9 | 27 | 40 | M | Testis | Seminoma | T1bN0M0 | - | I | Malignant | |
D1 | 28 | 24 | M | Testis | Embryonal carcinoma | T2N0M0 | - | I | Malignant | |
D2 | 29 | 36 | M | Thyroid gland | Medullary carcinoma | T3N0M0 | - | II | Malignant | |
D3 | 30 | 28 | F | Thyroid gland | Papillary carcinoma | T2N1M0 | - | I | Malignant | |
D4 | 31 | 51 | F | Breast | Ductal carcinoma in situ | TisN0M0 | - | 0 | Malignant | |
D5 | 32 | 49 | F | Breast | Invasive carcinoma of no special type | T1cN0M0 | 1 | IA | Malignant | |
D6 | 33 | 49 | F | Breast | Invasive carcinoma of no special type | T2N1M0 | 2 | IIB | Malignant | |
D7 | 34 | 57 | M | Spleen | Diffuse B-cell lymphoma | - | - | - | Malignant | |
D8 | 35 | 58 | M | Lung | Small cell carcinoma | T2aN0M0 | - | IB | Malignant | |
D9 | 36 | 67 | M | Lung | Small cell carcinoma | T2aN0M0 | - | IB | Malignant | |
E1 | 37 | 72 | F | Lung | Adenosquamous carcinoma | T3N1M0 | - | IIIA | Malignant | |
E2 | 38 | 68 | M | Esophagus | Squamous cell carcinoma | T3N3M0 | 1 | IVA | Malignant | |
E3 | 39 | 54 | F | Esophagus | Adenocarcinoma | T2N0M0 | 3 | IIA | Malignant | |
E4 | 40 | 63 | M | Stomach | Adenocarcinoma | T3N0M0 | 3 | IIA | Malignant | |
E5 | 41 | 59 | M | Small intestine | Adenocarcinoma | T2N0M0 | 2 | I | Malignant | |
E6 | 42 | 56 | M | Small intestine | Gastrointestinal stromal tumors, GIST | T3N0M0 | - | IB | Malignant | |
E7 | 43 | 61 | M | Colon | Adenocarcinoma | T3N2aM0 | 2 | IIIB | Malignant | |
E8 | 44 | 41 | M | Colon | Gastrointestinal stromal tumors, GIST | T3N0M0 | - | II | Malignant | |
E9 | 45 | 60 | M | Rectum | Adenocarcinoma | T3N1aM0 | 2 | IIIB | Malignant | |
F1 | 46 | 46 | M | Rectum | Gastrointestinal stromal tumors, GIST | T2N0M0 | - | IIB | Malignant | |
F2 | 47 | 67 | M | Liver | Hepatocellular carcinoma | T3N0M0 | 3 | IIIA | Malignant | |
F3 | 48 | 3 | F | Liver | Hepatoblastoma | - | - | - | Malignant | |
F4 | 49 | 54 | M | Kidney | Clear cell carcinoma | T1bN0M0 | 1 | I | Malignant | |
F5 | 50 | 71 | M | Prostate | Adenocarcinoma (Gleason grade:5, Gleason score:5+4) | T40N0M0 | 3 | IIIB | Malignant | |
F6 | 51 | 71 | M | Prostate | Adenocarcinoma (Gleason grade:1, Gleason score:3+3) | T3bN0M0 | 1 | IIIB | Malignant | |
F7 | 52 | 62 | F | Uterus | Endometrioid adenocarcinoma | T2N0M0 | 2 | II | Malignant | |
F8 | 53 | 65 | F | Uterus | Epithelioid leiomyosarcoma,G2 | T1aN0M0 | - | IA | Malignant | |
F9 | 54 | 56 | F | Uterus | Clear cell carcinoma | T1bN0M0 | - | IB | Malignant | |
G1 | 55 | 66 | F | Cervix | Squamous cell carcinoma | T2a2N0M0 | 2 | IIA2 | Malignant | |
G2 | 56 | 59 | F | Cervix | Squamous cell carcinoma | T1b2N0M0 | 3 | IB2 | Malignant | |
G3 | 57 | 24 | M | Right neck | Embryonal rhabdomyosarcom ,G3 | T2bN0M0 | - | III | Malignant | |
G4 | 58 | 52 | F | Right toe | Malignant melanoma | T4bN2bM0 | - | IIIB | Malignant | |
G5 | 59 | 61 | M | Skin/Left face | Basal cell carcinoma | T2N0M0 | - | II | Malignant | |
G6 | 60 | 83 | M | Skin/Left neck | Squamous cell carcinoma | T3N1M0 | 2 | III | Malignant | |
G7 | 61 | 52 | M | Right thigh | Neurofibroma | - | - | - | Benign | |
G8 | 62 | 3 | F | Retroperitoneum | Neuroblastoma | T2N0M0 | Malignant | |||
G9 | 63 | 43 | M | pericardium | Malignant mesothelioma | T2N0M0 | II | Malignant | ||
H1 | 64 | 53 | M | Lymph node/Axillary | Diffuse B cell lymphoma | - | - | - | Malignant | |
H2 | 65 | 81 | M | Lymph node/Cervical | Diffuse B cell lymphoma | - | - | - | Malignant | |
H3 | 66 | 35 | M | Lymph node/Cervical | Hodgkin's lymphoma | - | - | - | Malignant | |
H4 | 67 | 42 | M | Lymph node/Celiac | Anaplastic large cell lymphoma | - | - | - | Malignant | |
H5 | 68 | 67 | M | Bladder | Low grade invasive urothelial carcinoma | T1N0M0 | - | I | Malignant | |
H6 | 69 | 42 | M | Bladder | Leiomyosarcoma,G1 | T1N0M0 | - | I | Malignant | |
H7 | 70 | 40 | F | Bone/Femur | Osteosarcoma | T2N0M0 | - | IIIA | Malignant | |
H8 | 71 | 52 | F | Pelvic cavity | Spindle cell rhabdomyosarcoma,G3 | T4bN0M0 | - | IIIB | Malignant | |
H9 | 72 | 48 | F | Broad ligament/Left | Leiomyosarcoma,G2 | T2N0M0 | - | IIB | Malignant | |
- | 0 | 42 | M | Adrenal gland | Pheochromocytoma (tissue marker) | - | Malignant |
Find overlapping cases with this tissue array:
- Product Code: FDA808m-2
- Availability: In Stock